New Discoveries Could Broaden Topical Antihistamine Use

by U.S. Medicine

December 5, 2013

SAN FRANCISCO – New discoveries could change the way antihistamines are used from a predominantly systemic to a topical approach, according to an article from the San Francisco VAMC and the University of California in San Francisco.

The report, published this year in the Journal of Investigative Dermatology, noted that systemic antagonists of the histamine type 1 and 2 receptors (H1/2r) are widely used as anti-pruritics and central sedatives but demonstrate only modest anti-inflammatory activity.1

Because many inflammatory dermatoses result from defects in cutaneous barrier function, and because keratinocytes express both Hr1 and Hr2, researchers hypothesized that H1/2r antagonists might be more effective if they were used topically to treat inflammatory dermatoses.

They found that topical H1/2r antagonists additively enhanced permeability barrier homeostasis in normal mouse skin by the following mechanisms: (i) stimulation of epidermal differentiation, leading to thickened cornified envelopes; and (ii) enhanced epidermal lipid synthesis and secretion. As barrier homeostasis was enhanced to a comparable extent in mast cell-deficient mice, with no further improvement following application of topical H1/2r antagonists, H1/2r antagonists likely oppose mast cell-derived histamines.

In fact, topical H1/2r agonists aggravated, whereas H1/2r antagonists improved, inflammation and/or barrier function in four immunologically diverse, disease models in mice, characterized by either inflammation alone (acute irritant contact dermatitis, acute allergic contact dermatitis) or by prominent barrier abnormalities (subacute allergic contact dermatitis, atopic dermatitis).

“The apparent ability of topical H1r/2r antagonists to target epidermal H1/2r could translate into increased efficacy in the treatment of inflammatory dermatoses, likely due to decreased inflammation and enhanced barrier function,” according to study authors, who added, “These results could shift current paradigms of antihistamine utilization from a predominantly systemic to a topical approach.”

1.    Lin TK, Man MQ, Santiago JL, Park K, Roelandt T, Oda Y, Hupe M, Crumrine D, Lee HJ, Gschwandtner M, Thyssen JP, Trullas C, Tschachler E, Feingold KR, Elias PM. Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function. J Invest Dermatol. 2013 Feb;133(2):469-78. doi: 0.1038/jid.2012.335. Epub 2012 Sep 27. PubMed PMID:23014339; PubMed Central PMCID: PMC3532566.


Comments are closed here.


Related Articles

What Will Be Cost of VA’s Legacy EHR System During Changeover?

GAO Suggests VistA Will Be Around for Next Decade WASHINGTON—As VA moves forward with the comprehensive overhaul of its electronic health records system, the department will still need to keep its legacy EHR system functioning... View Article

Five Miles High? VA Document Backlog Is Stacking Up, OIG Reports

WASHINGTON—If stacked, VA’s backlog of paper medical documents that are waiting to be digitalized—most generated by veterans’ visits to non-VA providers—would be over 5 miles high, according to a report from the VA inspector general.... View Article


U.S. Medicine Recommends


More From department of veterans affairs

Department of Veterans Affairs (VA)

What Will Be Cost of VA’s Legacy EHR System During Changeover?

GAO Suggests VistA Will Be Around for Next Decade WASHINGTON—As VA moves forward with the comprehensive overhaul of its electronic health records system, the department will still need to keep its legacy EHR system functioning... View Article

Department of Veterans Affairs (VA)

Five Miles High? VA Document Backlog Is Stacking Up, OIG Reports

WASHINGTON—If stacked, VA’s backlog of paper medical documents that are waiting to be digitalized—most generated by veterans’ visits to non-VA providers—would be over 5 miles high, according to a report from the VA inspector general.... View Article

Department of Veterans Affairs (VA)

Year Supply of Contraceptives Prevents More Unintended Pregnancies

Birth Control Pill Change Could Save VA $2 Million Annually PITTSBURGH—What if there was a method to prevent nearly 600 unintended pregnancies and save the VA about $2 million a year in prenatal, birth and... View Article

Department of Veterans Affairs (VA)

VA Says It Is Working to Resolve Whistleblower Retaliation Issues

WASHINGTON—According to VA officials, the agency is well on its way to creating a culture that will allow whistleblowers to feel safe to report facility problems without fear of retaliation from supervisors. Yet, whistleblower advocates... View Article

Department of Veterans Affairs (VA)

Genetic Mutations Affecting Response to Drugs Are Common in Veterans

VA Debates Who Should Receive Pharmacogenetic Testing SALT LAKE CITY—A massive VA study revealed that 99% of veterans have at least one genetic mutation known to affect response to specific drugs, including some commonly prescribed... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up